LYTIX BIOPHARMA ASA: årsregnskap 2010 vs 2009
Mixed movements in the accounts
Summary
What changed
Comparing Årsregnskap 2010 with 2009 for LYTIX BIOPHARMA ASA. Equity 72.04m NOK → 79.59m NOK.
On the constructive side: equity strengthened; owners injected capital. Pressures included: operating result weakened; cash fell.
Mixed year — gains and pressures both show up.
At a glance
Scorecard
Revenue
n/m
0 NOK
—
Operating result
-28.06m NOK
-41.87m NOK
-49.2%
Net result
-26.37m NOK
n/m
—
Equity
72.04m NOK
79.59m NOK
+10.5%
Cash
70.90m NOK
35.74m NOK
-49.6%
Total assets
84.90m NOK
91.12m NOK
+7.3%
What improved
-
↑
Equity strengthened
Book equity 72.04m NOK → 79.59m NOK (equity ratio 84.9% → 87.3%). Calculated
-
↑
Owners injected capital
Paid-in equity rose 72.04m NOK → 79.59m NOK (+7.55m NOK). Reported fact
What deteriorated
-
↓
Operating result weakened
Operating result -28.06m NOK → -41.87m NOK. Calculated
-
↓
Cash fell
Bank deposits 70.90m NOK → 35.74m NOK (-49.6% YoY). Calculated